Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • novino11
    Junior Member
    • Jun 2011
    • 2

    #1

    experimental versus control enrichemnt for chip seq data

    Hi all
    I have done few chips using antibody against a transcription factor in honeybee. I also used pre immune IgG (from the animal where antibody was generated) and did chip in identical way. I have now used input as control and have found peaks in both the experimental chip data and the control (chip using pre immune IgG ) data.
    Some of the peaks found in experimental dataset are also turning up in control dataset. However, the fold enrichment differs- say if the experimental dataset shows an enrichment of 100 fold, the control dataset shows enrichment of 10 fold.
    To get the final data- should i subtract the control dataset from experimental in a quantitative manner or just qualitative way. I mean should I consider the fold enrichment while subtraction or should I just ignore it

    Thanks
    naveen
  • biznatch
    Senior Member
    • Nov 2010
    • 124

    #2
    I don't think there's a perfectly agreed upon way to subtract input or IgG control from the experimental sample, I've tried looking for the same thing. If you just need to identify peaks, you can use various peak calling programs that take input into consideration using various algorithms when identifying them. Some peak calling programs. I don't know if they all consider input, I've only used SISSRS, which does.

    These are some previous threads discussing normalization to input:

    Any non-primary sequence heritable modification of genetic material. ChIP-SEQ, DNA methylation (Bisulfite-SEQ), chromatin modifications (methylation, acetylation, etc), non coding RNA.

    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...